ToolGen Incorporated (KOSDAQ:199800)
South Korea · Delayed Price · Currency is KRW 27,900
-600 (-2.11%)
Oct 23, 2026, 3:30 PM KST
ToolGen Revenue
ToolGen had revenue of 487.20M KRW in the quarter ending June 30, 2026, with 163.05% growth. This brings the company's total for the last twelve months to 1.83B, up 88.85% year-over-year. In the year 2025, ToolGen had annual revenue of 1.31B with 46.63% growth. That makes ToolGen the 43,073rd largest company in the world by revenue and 2,575th in South Korea.
Revenue (ttm)
1.83B
Revenue Growth
+88.85%
P/S Ratio
149.20
Revenue / Employee
28.11M
Employees
65
Market Cap
272.64B
Revenue by Geography
- North America 586.95M 44.9%
- Korea 304.92M 23.3%
- Asia, Etc. 298.31M 22.8%
- Europe 116.27M 8.9%
Fiscal year ended Dec 31, 2025 See the full ToolGen breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.31B | 415.48M | 46.63% |
| Dec 31, 2024 | 890.96M | -212.45M | -19.25% |
| Dec 31, 2023 | 1.10B | 359.95M | 48.41% |
| Dec 31, 2022 | 743.46M | -853.81M | -53.45% |
| Dec 31, 2021 | 1.60B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Value Added Technology | 441.04B |
| Vieworks | 244.28B |
| T&L Co., Ltd. | 175.16B |
| Boditech Med | 174.78B |
| WON TECH | 167.35B |
| BioNote | 126.41B |
| Bio Plus | 99.15B |
| Curexo | 77.74B |